Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
database[Title] 2023-02-15
Summary:
BACKGROUND: The development of novel therapies for patients with sarcoma is challenging due to the rarity and diversity of these mesenchymal neoplasms. Hence, histology-agnostic approvals can be of particular interest for the treatment of patients with soft tissue and bone sarcoma.